Insight Wellness, Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1325 N River St Ste 206, Plains, PA 18702 Phone: 570-550-4231 |
Brooke E. Egbert, Psy.d., Llc Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1325 N River St, Suite 206, Plains, PA 18702 Phone: 570-899-8902 Fax: 570-824-5417 |
Brooke E. Egbert, Psy.d., Llc Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 1325 N River St, Suite 206, Plains, PA 18702 Phone: 570-899-8902 Fax: 570-824-5417 |
Traci Muracco, Lpc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1325 N River St, Plains, PA 18702 Phone: 570-905-7945 Fax: 570-824-5417 |
Traci Muracco Llc Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 1325 N River St, Plains, PA 18702 Phone: 570-905-7945 |
Nls Aba Services Llc Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1086 Route 315, Plains, PA 18702 Phone: 570-823-7761 Fax: 570-822-8033 |
News Archive
A form of gene therapy protects optic nerve cells and preserves vision in mouse models of glaucoma, according to research supported by NIH's National Eye Institute.
In a latest break through, scientists have found a new technique to alter the genetic code behind hundreds of diseases and this was hailed by U.S. scientists as a "miracle of modern medicine." Genes responsible for devastating diseases can be corrected by controlling faulty messenger cells that are central to the body's protein production, researchers said Wednesday.
A new online resource to assist healthcare professionals in the development of shared care agreements for lisdexamfetamine dimesylate (Elvanse) has been launched by the Centre for Medicines Optimisation, Keele University - available at www.esca-keele.co.uk/lisdexamfetamine.
Adding the monoclonal antibody bavituximab to docetaxel chemotherapy doubles overall response rate and improves progression-free survival and overall survival in late-stage non-squamous, non-small cell lung cancer (NS-NSCLC) patients who have already received one prior chemotherapy regimen, according to research presented at the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.
› Verified 7 days ago